Cost-Effectiveness of First-Line S-1 Therapy for Metastatic Breast Cancer Patients Compared with Taxanes- An Analysis Based on the Randomized Phase III Select BC Trial
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2235
https://www.valueinhealthjournal.com/article/S1098-3015(16)33601-4/fulltext
Title :
Cost-Effectiveness of First-Line S-1 Therapy for Metastatic Breast Cancer Patients Compared with Taxanes- An Analysis Based on the Randomized Phase III Select BC Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33601-4&doi=10.1016/j.jval.2016.09.2235
First page :
A737
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2121